{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:33:25Z","timestamp":1792784005820,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Minnesota, Medical School, Grant-in-Aid","award":["212588"],"award-info":[{"award-number":["212588"]}],"id":[{"id":"https:\/\/ror.org\/017zqws13","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The North American Skull Base Society Research Grant","award":["21-22-NCE"],"award-info":[{"award-number":["21-22-NCE"]}],"id":[{"id":"https:\/\/ror.org\/008vhq233","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11102-025-01516-1","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T22:48:06Z","timestamp":1743893286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic models of Cushing\u2019s disease"],"prefix":"10.1007","volume":"28","author":[{"given":"Hiba","family":"Hashmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusaku","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4451-1668","authenticated-orcid":false,"given":"Takako","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"issue":"1","key":"1516_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s1042-3680(02)00017-7","volume":"14","author":"AP Amar","year":"2003","unstructured":"Amar AP, Weiss MH (2003) Pituitary anatomy and physiology. Neurosurg Clin N Am 14(1):11\u2013v. https:\/\/doi.org\/10.1016\/s1042-3680(02)00017-7","journal-title":"Neurosurg Clin N Am"},{"key":"1516_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jcp.s1-7.1.1","volume":"7","author":"PM Daniel","year":"1976","unstructured":"Daniel PM (1976) Anatomy of the hypothalamus and pituitary gland. J Clin Pathol Suppl (Assoc Clin Pathol) 7:1\u20137. https:\/\/doi.org\/10.1136\/jcp.s1-7.1.1","journal-title":"J Clin Pathol Suppl (Assoc Clin Pathol)"},{"issue":"6","key":"1516_CR3","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB (2022) Clinical biology of the pituitary adenoma. Endocr Rev 43(6):1003\u20131037. https:\/\/doi.org\/10.1210\/endrev\/bnac010","journal-title":"Endocr Rev"},{"issue":"10418","key":"1516_CR4","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","volume":"402","author":"M Gadelha","year":"2023","unstructured":"Gadelha M, Gatto F, Wildemberg LE, Fleseriu M (2023) Cushing\u2019s syndrome. Lancet 402(10418):2237\u20132252. https:\/\/doi.org\/10.1016\/S0140-6736(23)01961-X","journal-title":"Lancet"},{"issue":"6","key":"1516_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s0092-8674(01)00282-3","volume":"104","author":"B Lamolet","year":"2001","unstructured":"Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, Drouin J (2001) A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104(6):849\u2013859. https:\/\/doi.org\/10.1016\/s0092-8674(01)00282-3","journal-title":"Cell"},{"issue":"11","key":"1516_CR6","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.1128\/MCB.17.11.6673","volume":"17","author":"G Poulin","year":"1997","unstructured":"Poulin G, Turgeon B, Drouin J (1997) NeuroD1\/beta2 contributes to cell-specific transcription of the proopiomelanocortin gene. Mol Cell Biol 17(11):6673\u20136682. https:\/\/doi.org\/10.1128\/MCB.17.11.6673","journal-title":"Mol Cell Biol"},{"issue":"11","key":"1516_CR7","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1172\/JCI11182","volume":"106","author":"C Bousquet","year":"2000","unstructured":"Bousquet C, Zatelli MC, Melmed S (2000) Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing. J Clin Investig 106(11):1417\u20131425. https:\/\/doi.org\/10.1172\/JCI11182","journal-title":"J Clin Investig"},{"issue":"4","key":"1516_CR8","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/S0021-9258(17)43332-1","volume":"259","author":"JH Eberwine","year":"1984","unstructured":"Eberwine JH, Roberts JL (1984) Glucocorticoid regulation of pro-opiomelanocortin gene transcription in the rat pituitary. J Biol Chem 259(4):2166\u20132170","journal-title":"J Biol Chem"},{"issue":"7","key":"1516_CR9","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1210\/mend.16.7.0863","volume":"16","author":"D Kovalovsky","year":"2002","unstructured":"Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E (2002) Activation and induction of NUR77\/NURR1 in corticotrophs by CRH\/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Mol Endocrinol 16(7):1638\u20131651. https:\/\/doi.org\/10.1210\/mend.16.7.0863","journal-title":"Mol Endocrinol"},{"issue":"21","key":"1516_CR10","doi-asserted-by":"publisher","first-page":"8555","DOI":"10.1073\/pnas.1306182110","volume":"110","author":"L Du","year":"2013","unstructured":"Du L, Bergsneider M, Mirsadraei L, Young SH, Jonker JW, Downes M, Yong WH, Evans RM, Heaney P (2013) Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease. Proc Natl Acad Sci USA 110(21):8555\u20138560. https:\/\/doi.org\/10.1073\/pnas.1306182110","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1516_CR11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1530\/ERC-16-0206","volume":"23","author":"T Araki","year":"2016","unstructured":"Araki T, Liu NA, Tone Y, Cuevas-Ramos D, Heltsley R, Tone M, Melmed S (2016) E2F1-mediated human POMC expression in ectopic Cushing\u2019s syndrome. Endocr Relat Cancer 23(11):857\u2013870. https:\/\/doi.org\/10.1530\/ERC-16-0206","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"1516_CR12","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1101\/gad.10.10.1284","volume":"10","author":"T Lamonerie","year":"1996","unstructured":"Lamonerie T, Tremblay JJ, Lanct\u00f4t C, Therrien M, Gauthier Y, Drouin J (1996) Ptx1, a bicoid-related homeo box transcription factor involved in transcription of the pro-opiomelanocortin gene. Genes Dev 10(10):1284\u20131295. https:\/\/doi.org\/10.1101\/gad.10.10.1284","journal-title":"Genes Dev"},{"issue":"1","key":"1516_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Reincke","year":"2015","unstructured":"Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F (2015) Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat Genet 47(1):31\u201338. https:\/\/doi.org\/10.1038\/ng.3166","journal-title":"Nat Genet"},{"issue":"9","key":"1516_CR14","doi-asserted-by":"publisher","first-page":"e3346","DOI":"10.1210\/clinem\/dgab387","volume":"106","author":"T Araki","year":"2021","unstructured":"Araki T, Tone Y, Yamamoto M, Kameda H, Ben-Shlomo A (2021) Two distinctive POMC promoters modify gene expression in Cushing disease. J Clin Endocrinol Metab 106(9):e3346\u2013e3363. https:\/\/doi.org\/10.1210\/clinem\/dgab387","journal-title":"J Clin Endocrinol Metab"},{"key":"1516_CR15","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1210\/JC.2015-1453","volume":"100","author":"LG Perez-Rivas","year":"2015","unstructured":"Perez-Rivas LG, Theodoropoulou M, Ferra\u00f9 F, Nusser C, Kawaguchi K, Stratakis CA, Rueda Faucz F, Wildemberg LE, Assi\u00e9 G, Beschorner R, Dimopoulou C, Buchfelder M, Popovic V, Berr CM, T\u00f3th M, Ardisasmita AI, Honegger J, Bertherat J, Gadelha MR, Beuschlein F, Stalla G, Komada M, Korbonits M, Reincke M (2015) The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing\u2019s disease. J Clin Endocrinol Metab 100:997\u20131004. https:\/\/doi.org\/10.1210\/JC.2015-1453","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1516_CR16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cr.2015.20","volume":"25","author":"ZY Ma","year":"2015","unstructured":"Ma ZY, Song ZJ, Chen JH, Wang YF, Li SQ, Zhou LF, Mao Y, Li YM, Hu RG, Zhang ZY et al (2015) Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease. Cell Res 25(3):306\u2013317. https:\/\/doi.org\/10.1038\/cr.2015.20","journal-title":"Cell Res"},{"issue":"13","key":"1516_CR17","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1128\/MCB.01566-06","volume":"27","author":"S Niendorf","year":"2007","unstructured":"Niendorf S, Oksche A, Kisser A et al (2007) Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo. Mol Cell Biol 27(13):5029\u20135039. https:\/\/doi.org\/10.1128\/MCB.01566-06","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1516_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1210\/js.2016-1053","volume":"1","author":"T Araki","year":"2017","unstructured":"Araki T, Liu X, Kameda H, Tone Y, Fukuoka H, Tone M, Melmed S (2017) EGFR induces E2F1-mediated corticotroph tumorigenesis. J Endocr Soc 1(2):127\u2013143. https:\/\/doi.org\/10.1210\/js.2016-1053","journal-title":"J Endocr Soc"},{"issue":"Suppl 1","key":"1516_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000178058","volume":"71","author":"C de Bruin","year":"2009","unstructured":"de Bruin C, Meij BP, Kooistra HS, Hanson JM, Lamberts SW, Hofland LJ (2009) Cushing\u2019s disease in dogs and humans. Horm Res 71(Suppl 1):140\u2013143. https:\/\/doi.org\/10.1159\/000178058","journal-title":"Horm Res"},{"key":"1516_CR20","doi-asserted-by":"publisher","first-page":"105623","DOI":"10.1016\/j.tvjl.2021.105623","volume":"270","author":"K Sanders","year":"2021","unstructured":"Sanders K, Galac S, Meij BP (2021) Pituitary tumour types in dogs and cats. Vet J 270:105623. https:\/\/doi.org\/10.1016\/j.tvjl.2021.105623","journal-title":"Vet J"},{"key":"1516_CR21","first-page":"717","volume":"18","author":"PW Willeberg","year":"1982","unstructured":"Willeberg PW, Priesterm WA (1982) Epidemiological aspects of clinical hyperadrenocorticism in dogs (canine Cushing\u2019s syndrome). J Am Anim Hosp Assoc 18:717\u2013724","journal-title":"J Am Anim Hosp Assoc"},{"issue":"7","key":"1516_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/jsap.12523","volume":"57","author":"DG O'Neill","year":"2016","unstructured":"O\u2019Neill DG, Scudder C, Faire JM, Church DB, McGreevy PD, Thomson PC, Brodbelt DC (2016) Epidemiology of hyperadrenocorticism among 210,824 dogs attending primary-care veterinary practices in the UK from 2009 to 2014. J Small Anim Pract 57(7):365\u2013373. https:\/\/doi.org\/10.1111\/jsap.12523","journal-title":"J Small Anim Pract"},{"issue":"12","key":"1516_CR23","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1172\/JCI60417","volume":"121","author":"H Fukuoka","year":"2011","unstructured":"Fukuoka H, Cooper O, Ben-Shlomo A, Mamelak A, Ren SG, Bruyette D, Melmed S (2011) EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas. J Clin Investig 121(12):4712\u20134721. https:\/\/doi.org\/10.1172\/JCI60417","journal-title":"J Clin Investig"},{"issue":"1","key":"1516_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12902-021-00845-z","volume":"21","author":"A Wang","year":"2021","unstructured":"Wang A, Neill SG, Newman S, Tryfonidou MA, Ioachimescu A, Rossi MR, Meij BP, Oyesiku NM (2021) The genomic profiling and MAMLD1 expression in human and canines with Cushing\u2019s disease. BMC Endocr Disord 21(1):185. https:\/\/doi.org\/10.1186\/s12902-021-00845-z","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"1516_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3181\/00379727-84-20607","volume":"84","author":"J Furth","year":"1953","unstructured":"Furth J, Gadsen EL, Upton AC (1953) ACTH secreting transplantable pituitary tumors. Proc Soc Exp Biol Med Soc Exp Biol Med 84(1):253\u2013254. https:\/\/doi.org\/10.3181\/00379727-84-20607","journal-title":"Proc Soc Exp Biol Med Soc Exp Biol Med"},{"issue":"7","key":"1516_CR26","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1073\/pnas.48.7.1184","volume":"48","author":"V Buonassisi","year":"1962","unstructured":"Buonassisi V, Sato G, Cohen AI (1962) Hormone-producing cultures of adrenal and pituitary tumor origin. Proc Natl Acad Sci USA 48(7):1184\u20131190. https:\/\/doi.org\/10.1073\/pnas.48.7.1184","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"1516_CR27","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1101\/gad.1444606","volume":"20","author":"S Bilodeau","year":"2006","unstructured":"Bilodeau S, Vallette-Kasic S, Gauthier Y, Figarella-Branger D, Brue T, Berthelet F, Lacroix A, Batista D, Stratakis C, Hanson J et al (2006) Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev 20(20):2871\u20132886. https:\/\/doi.org\/10.1101\/gad.1444606","journal-title":"Genes Dev"},{"issue":"5","key":"1516_CR28","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1210\/me.2004-0425","volume":"19","author":"M Nudi","year":"2005","unstructured":"Nudi M, Ouimette JF, Drouin J (2005) Bone morphogenic protein (smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx\/Tpit activity. Mol Endocrinol (Baltimore, Md) 19(5):1329\u20131342. https:\/\/doi.org\/10.1210\/me.2004-0425","journal-title":"Mol Endocrinol (Baltimore, Md)"},{"issue":"3","key":"1516_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF00431389","volume":"396","author":"CK Leung","year":"1982","unstructured":"Leung CK, Paterson JA, Imai Y, Shiu RP (1982) Transplantation of ACTH-secreting pituitary tumor cells in athymic nude mice. Virchows Archiv A Pathol Anat Histol 396(3):303\u2013312. https:\/\/doi.org\/10.1007\/BF00431389","journal-title":"Virchows Archiv A Pathol Anat Histol"},{"key":"1516_CR30","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac173","author":"M Nishiyama","year":"2022","unstructured":"Nishiyama M, Iwasaki Y, Makino S (2022) Animal models of Cushing\u2019s syndrome. Endocrinology. https:\/\/doi.org\/10.1210\/endocr\/bqac173","journal-title":"Endocrinology"},{"issue":"20","key":"1516_CR31","doi-asserted-by":"publisher","first-page":"8414","DOI":"10.1073\/pnas.1018091108","volume":"108","author":"NA Liu","year":"2011","unstructured":"Liu NA, Jiang H, Ben-Shlomo A, Wawrowsky K, Fan XM, Lin S, Melmed S (2011) Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor. Proc Natl Acad Sci USA 108(20):8414\u20138419. https:\/\/doi.org\/10.1073\/pnas.1018091108","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1516_CR32","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/1097-0142(19800301)45:5<906::aid-cncr2820450513>3.0.co;2-h","volume":"45","author":"OS Pettengill","year":"1980","unstructured":"Pettengill OS, Sorenson GD, Wurster-Hill DH, Curphey TJ, Noll WW, Cate CC, Maurer LH (1980) Isolation and growth characteristics of continuous cell lines from small-cell carcinoma of the lung. Cancer 45(5):906\u2013918. https:\/\/doi.org\/10.1002\/1097-0142(19800301)45:5%3c906::aid-cncr2820450513%3e3.0.co;2-h","journal-title":"Cancer"},{"issue":"1","key":"1516_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1677\/jme.0.0030065","volume":"3","author":"A White","year":"1989","unstructured":"White A, Stewart MF, Farrell WE, Crosby SR, Lavender PM, Twentyman PR, Rees LH, Clark AJ (1989) Pro-opiomelanocortin gene expression and peptide secretion in human small-cell lung cancer cell lines. J Mol Endocrinol 3(1):65\u201370. https:\/\/doi.org\/10.1677\/jme.0.0030065","journal-title":"J Mol Endocrinol"},{"issue":"2","key":"1516_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1677\/jme.0.0150187","volume":"15","author":"A Picon","year":"1995","unstructured":"Picon A, Leblond-Francillard M, Raffin-Sanson ML, Lenne F, Bertagna X, de Keyzer Y (1995) Functional analysis of the human pro-opiomelanocortin promoter in the small cell lung carcinoma cell line DMS-79. J Mol Endocrinol 15(2):187\u2013194. https:\/\/doi.org\/10.1677\/jme.0.0150187","journal-title":"J Mol Endocrinol"},{"issue":"16","key":"1516_CR35","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1038\/sj.onc.1202635","volume":"18","author":"A Picon","year":"1999","unstructured":"Picon A, Bertagna X, de Keyzer Y (1999) Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors. Oncogene 18(16):2627\u20132633. https:\/\/doi.org\/10.1038\/sj.onc.1202635","journal-title":"Oncogene"},{"key":"1516_CR36","first-page":"1071","volume":"140","author":"A Helseth","year":"1992","unstructured":"Helseth A, Siegal GP, Haug E, Bautch VL (1992) Transgenic mice that develop pituitary tumors. A model for Cushing\u2019s disease. Am J Pathol 140:1071\u20131080","journal-title":"Am J Pathol"},{"issue":"8","key":"1516_CR37","first-page":"2087","volume":"8","author":"V Paquis-Flucklinger","year":"1993","unstructured":"Paquis-Flucklinger V, Michiels JF, Vidal F, Alquier C, Pointis G, Bourdon V, Cuzin F, Rassoulzadegan M (1993) Expression in transgenic mice of the large T antigen of polyomavirus induces Sertoli cell tumours and allows the establishment of differentiated cell lines. Oncogene 8(8):2087\u20132094","journal-title":"Oncogene"},{"issue":"7","key":"1516_CR38","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.1128\/JVI.72.7.5329-5334.1998","volume":"72","author":"JL Brodsky","year":"1998","unstructured":"Brodsky JL, Pipas JM (1998) Polyomavirus T antigens: molecular chaperones for multiprotein complexes. J Virol 72(7):5329\u20135334. https:\/\/doi.org\/10.1128\/JVI.72.7.5329-5334.1998","journal-title":"J Virol"},{"issue":"5","key":"1516_CR39","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/sj.onc.1201552","volume":"16","author":"F Pacini","year":"1998","unstructured":"Pacini F, Vivaldi A, Santoro M, Fedele M, Fusco A, Romei C, Basolo F, Pinchera A (1998) Simian virus 40-like DNA sequences in human papillary thyroid carcinomas. Oncogene 16(5):665\u2013669. https:\/\/doi.org\/10.1038\/sj.onc.1201552","journal-title":"Oncogene"},{"issue":"4824","key":"1516_CR40","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1126\/science.2821617","volume":"238","author":"DM Ornitz","year":"1987","unstructured":"Ornitz DM, Hammer RE, Messing A, Palmiter RD, Brinster RL (1987) Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science (New York, NY) 238(4824):188\u2013193. https:\/\/doi.org\/10.1126\/science.2821617","journal-title":"Science (New York, NY)"},{"key":"1516_CR41","first-page":"552","volume":"129","author":"D Murphy","year":"1987","unstructured":"Murphy D, Bishop A, Rindi G, Murphy MN, Stamp GW, Hanson J, Polak JM, Hogan B (1987) Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1. Am J Pathol 129:552\u2013566","journal-title":"Am J Pathol"},{"issue":"10","key":"1516_CR42","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1210\/en.2015-1293","volume":"156","author":"AK Lee","year":"2015","unstructured":"Lee AK, Tse FW, Tse A (2015) Arginine vasopressin potentiates the stimulatory action of CRH on pituitary corticotropes via a protein kinase C-dependent reduction of the background TREK-1 current. Endocrinology 156(10):3661\u20133672. https:\/\/doi.org\/10.1210\/en.2015-1293","journal-title":"Endocrinology"},{"issue":"33","key":"1516_CR43","doi-asserted-by":"publisher","first-page":"24967","DOI":"10.1016\/S0021-9258(19)74558-X","volume":"268","author":"MJ Low","year":"1993","unstructured":"Low MJ, Liu B, Hammer GD, Rubinstein M, Allen RG (1993) Post-translational processing of proopiomelanocortin (POMC) in mouse pituitary melanotroph tumors induced by a POMC-simian virus 40 large T antigen transgene. J Biol Chem 268(33):24967\u201324975","journal-title":"J Biol Chem"},{"issue":"2","key":"1516_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s1535-6108(02)00102-2","volume":"2","author":"CJ Sherr","year":"2002","unstructured":"Sherr CJ, McCormick F (2002) The RB and p53 pathways in cancer. Cancer Cell 2(2):103\u2013112. https:\/\/doi.org\/10.1016\/s1535-6108(02)00102-2","journal-title":"Cancer Cell"},{"issue":"5","key":"1516_CR45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/jnci\/djh058","volume":"96","author":"O Fletcher","year":"2004","unstructured":"Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J (2004) Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 96(5):357\u2013363. https:\/\/doi.org\/10.1093\/jnci\/djh058","journal-title":"J Natl Cancer Inst"},{"issue":"6393","key":"1516_CR46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/359295a0","volume":"359","author":"T Jacks","year":"1992","unstructured":"Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359(6393):295\u2013300. https:\/\/doi.org\/10.1038\/359295a0","journal-title":"Nature"},{"issue":"8","key":"1516_CR47","first-page":"1615","volume":"10","author":"DJ Harrison","year":"1995","unstructured":"Harrison DJ, Hooper ML, Armstrong JF, Clarke AR (1995) Effects of heterozygosity for the Rb-1t19neo allele in the mouse. Oncogene 10(8):1615\u20131620","journal-title":"Oncogene"},{"issue":"3","key":"1516_CR48","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1128\/mcb.12.3.971-980.1992","volume":"12","author":"QJ Hu","year":"1992","unstructured":"Hu QJ, Lees JA, Buchkovich KJ, Harlow E (1992) The retinoblastoma protein physically associates with the human cdc2 kinase. Mol Cell Biol 12(3):971\u2013980. https:\/\/doi.org\/10.1128\/mcb.12.3.971-980.1992","journal-title":"Mol Cell Biol"},{"issue":"3","key":"1516_CR49","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1210\/jcem.77.3.7690360","volume":"77","author":"VL Cryns","year":"1993","unstructured":"Cryns VL, Alexander JM, Klibanski A, Arnold A (1993) The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab 77(3):644\u2013646. https:\/\/doi.org\/10.1210\/jcem.77.3.7690360","journal-title":"J Clin Endocrinol Metab"},{"issue":"4\u20135","key":"1516_CR50","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1387\/ijdb.103238ct","volume":"55","author":"C Tobia","year":"2011","unstructured":"Tobia C, De Sena G, Presta M (2011) Zebrafish embryo, a tool to study tumor angiogenesis. Int J Dev Biol 55(4\u20135):505\u2013509. https:\/\/doi.org\/10.1387\/ijdb.103238ct","journal-title":"Int J Dev Biol"},{"issue":"1","key":"1516_CR51","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/ERC-13-0388","volume":"21","author":"G Vitale","year":"2014","unstructured":"Vitale G, Gaudenzi G, Dicitore A, Cotelli F, Ferone D, Persani L (2014) Zebrafish as an innovative model for neuroendocrine tumors. Endocr Relat Cancer 21(1):R67-83. https:\/\/doi.org\/10.1530\/ERC-13-0388","journal-title":"Endocr Relat Cancer"},{"issue":"7446","key":"1516_CR52","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature12111","volume":"496","author":"K Howe","year":"2013","unstructured":"Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE, Humphray S, McLaren K, Matthews L et al (2013) The zebrafish reference genome sequence and its relationship to the human genome. Nature 496(7446):498\u2013503. https:\/\/doi.org\/10.1038\/nature12111","journal-title":"Nature"},{"issue":"4","key":"1516_CR53","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1210\/mend.11.4.9911","volume":"11","author":"L Pei","year":"1997","unstructured":"Pei L, Melmed S (1997) Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol (Baltimore, Md) 11(4):433\u2013441. https:\/\/doi.org\/10.1210\/mend.11.4.9911","journal-title":"Mol Endocrinol (Baltimore, Md)"},{"issue":"2","key":"1516_CR54","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1210\/jcem.84.2.5432","volume":"84","author":"X Zhang","year":"1999","unstructured":"Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S (1999) Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84(2):761\u2013767. https:\/\/doi.org\/10.1210\/jcem.84.2.5432","journal-title":"J Clin Endocrinol Metab"},{"issue":"43","key":"1516_CR55","doi-asserted-by":"publisher","first-page":"69149","DOI":"10.18632\/oncotarget.12381","volume":"7","author":"D Zhang","year":"2016","unstructured":"Zhang D, Bergsneider M, Wang MB, Heaney AP (2016) Targeting the ERK pathway for the treatment of Cushing\u2019s disease. Oncotarget 7(43):69149\u201369158. https:\/\/doi.org\/10.18632\/oncotarget.12381","journal-title":"Oncotarget"},{"issue":"7","key":"1516_CR56","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1210\/jc.2015-1606","volume":"100","author":"NA Liu","year":"2015","unstructured":"Liu NA, Araki T, Cuevas-Ramos D, Hong J, Ben-Shlomo A, Tone Y, Tone M, Melmed S (2015) Cyclin E-mediated human proopiomelanocortin regulation as a therapeutic target for Cushing disease. J Clin Endocrinol Metab 100(7):2557\u20132564. https:\/\/doi.org\/10.1210\/jc.2015-1606","journal-title":"J Clin Endocrinol Metab"},{"key":"1516_CR57","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac086","author":"T Araki","year":"2022","unstructured":"Araki T, Wang J, Lawrence R, Kawakami Y (2022) Aberrant nuclear translocation of E2F1 and its association in Cushing\u2019s disease. Endocrinology. https:\/\/doi.org\/10.1210\/endocr\/bqac086","journal-title":"Endocrinology"},{"issue":"2","key":"1516_CR58","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1530\/EJE-15-0689","volume":"174","author":"K Hayashi","year":"2016","unstructured":"Hayashi K, Inoshita N, Kawaguchi K, Ibrahim AA, Suzuki H, Fukuhara N, Okada M, Nishioka H, Takeuchi Y, Komada M et al (2016) The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing\u2019s disease. Eur J Endocrinol 174(2):213\u2013226. https:\/\/doi.org\/10.1530\/EJE-15-0689","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1516_CR59","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1210\/endo.130.6.1597149","volume":"130","author":"MP Stenzel-Poore","year":"1992","unstructured":"Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W (1992) Development of Cushing\u2019s syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 130(6):3378\u20133386. https:\/\/doi.org\/10.1210\/endo.130.6.1597149","journal-title":"Endocrinology"},{"issue":"11","key":"1516_CR60","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/s0006-3223(02)01334-3","volume":"51","author":"L Groenink","year":"2002","unstructured":"Groenink L, Dirks A, Verdouw PM, Schipholt M, Veening JG, van der Gugten J, Olivier B (2002) HPA axis dysregulation in mice overexpressing corticotropin releasing hormone. Biol Psychiat 51(11):875\u2013881. https:\/\/doi.org\/10.1016\/s0006-3223(02)01334-3","journal-title":"Biol Psychiat"},{"issue":"3","key":"1516_CR61","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1210\/en.2013-1247","volume":"155","author":"L Bentley","year":"2014","unstructured":"Bentley L, Esapa CT, Nesbit MA, Head RA, Evans H, Lath D, Scudamore CL, Hough TA, Podrini C, Hannan FM et al (2014) An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess. Endocrinology 155(3):908\u2013922. https:\/\/doi.org\/10.1210\/en.2013-1247","journal-title":"Endocrinology"},{"issue":"7","key":"1516_CR62","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1210\/er.2009-0008","volume":"30","author":"D Kelberman","year":"2009","unstructured":"Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT (2009) Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 30(7):790\u2013829. https:\/\/doi.org\/10.1210\/er.2009-0008","journal-title":"Endocr Rev"},{"key":"1516_CR63","doi-asserted-by":"publisher","first-page":"103294","DOI":"10.1016\/j.ebiom.2021.103294","volume":"66","author":"D Zhang","year":"2021","unstructured":"Zhang D, Hugo W, Redublo P, Miao H, Bergsneider M, Wang MB, Kim W, Yong WH, Heaney AP (2021) A human ACTH-secreting corticotroph tumoroid model: novel human ACTH-secreting tumor cell in vitro model. EBioMedicine 66:103294. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103294","journal-title":"EBioMedicine"},{"issue":"5","key":"1516_CR64","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","volume":"141","author":"T Sato","year":"2011","unstructured":"Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J, Siersema PD et al (2011) Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium. Gastroenterology 141(5):1762\u20131772. https:\/\/doi.org\/10.1053\/j.gastro.2011.07.050","journal-title":"Gastroenterology"},{"issue":"1\u20132","key":"1516_CR65","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj SF, Hwang CI, Baker LA, Chio II, Engle DD, Corbo V, Jager M, Ponz-Sarvise M, Tiriac H, Spector MS et al (2015) Organoid models of human and mouse ductal pancreatic cancer. Cell 160(1\u20132):324\u2013338. https:\/\/doi.org\/10.1016\/j.cell.2014.12.021","journal-title":"Cell"},{"issue":"4","key":"1516_CR66","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.celrep.2018.03.105","volume":"23","author":"J Ogawa","year":"2018","unstructured":"Ogawa J, Pao GM, Shokhirev MN, Verma IM (2018) Glioblastoma model using human cerebral organoids. Cell Rep 23(4):1220\u20131229. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.105","journal-title":"Cell Rep"},{"issue":"5","key":"1516_CR67","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.celrep.2013.10.048","volume":"5","author":"Z Dincer","year":"2013","unstructured":"Dincer Z, Piao J, Niu L, Ganat Y, Kriks S, Zimmer B, Shi SH, Tabar V, Studer L (2013) Specification of functional cranial placode derivatives from human pluripotent stem cells. Cell Rep 5(5):1387\u20131402. https:\/\/doi.org\/10.1016\/j.celrep.2013.10.048","journal-title":"Cell Rep"},{"issue":"6","key":"1516_CR68","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.stemcr.2016.05.005","volume":"6","author":"B Zimmer","year":"2016","unstructured":"Zimmer B, Piao J, Ramnarine K, Tomishima MJ, Tabar V, Studer L (2016) Derivation of diverse hormone-releasing pituitary cells from human pluripotent stem cells. Stem Cell Rep 6(6):858\u2013872. https:\/\/doi.org\/10.1016\/j.stemcr.2016.05.005","journal-title":"Stem Cell Rep"},{"key":"1516_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213344","author":"J Chakrabarti","year":"2022","unstructured":"Chakrabarti J, Pandey R, Churko JM, Eschbacher J, Mallick S (2022) Development of human pituitary neuroendocrine tumor organoids to facilitate effective targeted treatments of Cushing\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells11213344","journal-title":"Cells"},{"key":"1516_CR70","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.trsl.2023.01.002","volume":"256","author":"S Mallick","year":"2023","unstructured":"Mallick S, Chakrabarti J, Eschbacher J, Moraitis AG, Greenstein AE, Churko J, Pond KW, Livolsi A, Thorne CA, Little AS et al (2023) Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators. Transl Res J Lab Clin Med 256:56\u201372. https:\/\/doi.org\/10.1016\/j.trsl.2023.01.002","journal-title":"Transl Res J Lab Clin Med"},{"issue":"7375","key":"1516_CR71","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature10637","volume":"480","author":"H Suga","year":"2011","unstructured":"Suga H, Kadoshima T, Minaguchi M et al (2011) Self-formation of functional adenohypophysis in three-dimensional culture. Nature 480(7375):57\u201362. https:\/\/doi.org\/10.1038\/nature10637","journal-title":"Nature"},{"issue":"3","key":"1516_CR72","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1152\/physrev.00006.2006","volume":"87","author":"X Zhu","year":"2007","unstructured":"Zhu X, Gleiberman AS, Rosenfeld MG (2007) Molecular physiology of pituitary development: signaling and transcriptional networks. Physiol Rev 87(3):933\u2013963. https:\/\/doi.org\/10.1152\/physrev.00006.2006","journal-title":"Physiol Rev"},{"issue":"2","key":"1516_CR73","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1172\/JCI127378","volume":"130","author":"R Matsumoto","year":"2020","unstructured":"Matsumoto R, Suga H, Aoi T, Bando H, Fukuoka H, Iguchi G, Narumi S, Hasegawa T, Muguruma K, Ogawa W et al (2020) Congenital pituitary hypoplasia model demonstrates hypothalamic OTX2 regulation of pituitary progenitor cells. J Clin Investig 130(2):641\u2013654. https:\/\/doi.org\/10.1172\/JCI127378","journal-title":"J Clin Investig"},{"key":"1516_CR74","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1210\/js.2019-00243","volume":"3","author":"K Kanie","year":"2019","unstructured":"Kanie K, Bando H, Iguchi G, Muguruma K, Matsumoto R, Hidaka-Takeno R, Okimura Y, Yamamoto M, Fujita Y, Fukuoka H et al (2019) Pathogenesis of anti-PIT-1 antibody syndrome: PIT-1 presentation by HLA class I on anterior pituitary cells. J Endocr Soc 3:1969\u20131978. https:\/\/doi.org\/10.1210\/js.2019-00243","journal-title":"J Endocr Soc"},{"issue":"1","key":"1516_CR75","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.celrep.2019.12.009","volume":"30","author":"T Kasai","year":"2020","unstructured":"Kasai T, Suga H, Sakakibara M, Ozone C, Matsumoto R, Kano M, Mitsumoto K, Ogawa K, Kodani Y, Nagasaki H et al (2020) Hypothalamic contribution to pituitary functions is recapitulated in vitro using 3D-cultured human iPS cells. Cell Rep 30(1):18-24.e15. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.009","journal-title":"Cell Rep"},{"issue":"1","key":"1516_CR76","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13023-021-02061-3","volume":"16","author":"A Tisdale","year":"2021","unstructured":"Tisdale A, Cutillo CM, Nathan R, Russo P, Laraway B, Haendel M, Nowak D, Hasche C, Chan CH, Griese E et al (2021) The IDeaS initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems. Orphanet J Rare Dis 16(1):429. https:\/\/doi.org\/10.1186\/s13023-021-02061-3","journal-title":"Orphanet J Rare Dis"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01516-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-025-01516-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-025-01516-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T04:52:56Z","timestamp":1746507176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-025-01516-1"}},"subtitle":["From cells, in vivo transgenic models to human pituitary organoids"],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1516"],"URL":"https:\/\/doi.org\/10.1007\/s11102-025-01516-1","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"10 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"47"}}